| Docetaxel |
№ ІІ -9913/ 09.06.2010 |
DOCETAXEL ACTAVIS, Concentrate and solvent for solution for infusion, 20 mg/ 0.5 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan-Pharma S.R.L., Румъния |
45 |
9 |
54 |
4% |
1.8 |
46.8 |
9.36 |
56.16 |
16% |
7.2 |
54 |
10.8 |
64.8 |
Цената е заличена с решение НСР-4982/05.11.2014 (в сила от 02.12.2014 ); НСР-5081/21.11.2014 |
КЦ-1823/11.10.2010 |
25.10.2010 |
25.10.2010 |
Заличен |
1918 |
| Docetaxel |
20100564 |
DOCETAXEL ACTAVIS, Concentrate for solution for infusion, 140 mg/7 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan Pharma SRL Romania |
347.75 |
69.55 |
417.3 |
4% |
10 |
357.75 |
71.55 |
429.3 |
16% |
25 |
382.75 |
76.55 |
459.3 |
корекц. решение КЦРР-1262/15.08.2012 |
КЦРР-1044/26.07.2012 |
10.08.2012 |
10.08.2012 |
Неактивен |
1472 |
| Docetaxel |
20100564 |
DOCETAXEL ACTAVIS, Concentrate for solution for infusion, 140 mg/7 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan Pharma SRL Romania; Actavis Italy S.p.a., Nerviano Plant, Italy |
103.66 |
20.73 |
124.39 |
4% |
4.15 |
107.81 |
21.56 |
129.37 |
16% |
16.59 |
124.4 |
24.88 |
149.28 |
промяна на обстоятелства решение НСР-586/23.07.2013; Цената се заличава с решение НСР-3091/21.03.2014 |
HCР-456/09.07.2013. |
25.07.2013 |
25.07.2013 |
Заличен |
1472 |
| Docetaxel |
20100564 |
DOCETAXEL ACTAVIS, Concentrate for solution for infusion, 20 mg/1 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan Pharma SRL Romania; Actavis Italy S.p.a., Nerviano Plant, Italy |
29.94 |
5.99 |
35.93 |
6% |
1.8 |
31.74 |
6.35 |
38.09 |
18% |
5.39 |
37.13 |
7.43 |
44.56 |
промяна на обстоятелства решение НСР-586/23.07.2013 |
HCР-467/09.07.2013. |
25.07.2013 |
25.07.2013 |
Неактивен |
1463 |
| Docetaxel |
20100564 |
DOCETAXEL ACTAVIS, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C.Sindan Pharma SRL Romania |
195.58 |
39.12 |
234.7 |
4% |
7.82 |
203.4 |
40.68 |
244.08 |
16% |
25 |
228.4 |
45.68 |
274.08 |
корекц. решение КЦРР-1265/15.08.2012 |
КЦРР-959/16.07.2012 |
06.08.2012 |
06.08.2012 |
Неактивен |
1462 |
| Docetaxel |
20140187 |
Docetaxel AqVida, Concentrate for solution for infusion, 20 mg/ml-4ml, -, Pack: 1 |
AqVida GmbH, Германия |
AqVida GmbH Kaiser-Wilhelm Str.89, 20355 Hamburg, Германия |
63.1 |
12.62 |
75.72 |
4% |
2.52 |
65.62 |
13.12 |
78.74 |
16% |
10.1 |
75.72 |
15.14 |
90.86 |
|
НСР-14245/19.10.2017 |
03.11.2017 |
02.12.2017 |
Активен |
15916 |
| Docetaxel |
20200053 |
Docetaxel Bulgermed, Concentrate for solution for infusion, 20 mg/ml - 8 ml, -, Pack: 1 |
Булгермед ВЕ ООД, България |
AqVida GmbH, Германия |
53.26 |
10.65 |
63.91 |
4% |
2.13 |
55.39 |
11.08 |
66.47 |
16% |
8.52 |
63.91 |
12.78 |
76.69 |
|
НСР-21736/25.06.2020 |
10.07.2020 |
02.08.2020 |
Активен |
17010 |
| Docetaxel |
20200053 |
Docetaxel Bulgermed, Concentrate for solution for infusion, 20 mg/ml - 4 ml, -, Pack: 1 |
Булгермед ВЕ ООД, България |
AqVida GmbH, Германия |
63.1 |
12.62 |
75.72 |
4% |
2.52 |
65.62 |
13.12 |
78.74 |
16% |
10.1 |
75.72 |
15.14 |
90.86 |
|
НСР-21736/25.06.2020 |
10.07.2020 |
02.08.2020 |
Активен |
17009 |
| Docetaxel |
20100475 |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 8 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK Ltd. QUEENSWAY, Великобритания, Hospira Enterprises B.V. Randstad 22-11 1316 BN Almere, Нидерландия |
62.06 |
12.41 |
74.47 |
4% |
2.48 |
64.54 |
12.91 |
77.45 |
16% |
9.93 |
74.47 |
14.89 |
89.36 |
промяна в обстоятелствата НСР-6938/12.08.2015 |
НСР-3734/06.06.2014; НСР-12054/21.03.2017 |
23.06.2014 |
02.05.2017 |
Заличен |
2925 |
| Docetaxel |
20100475 |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 8 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK Ltd. QUEENSWAY, Великобритания, Hospira Enterprises B.V. Randstad 22-11 1316 BN Almere, Нидерландия |
62.06 |
12.41 |
74.47 |
4% |
2.48 |
64.54 |
12.91 |
77.45 |
16% |
9.93 |
74.47 |
14.89 |
89.36 |
промяна в обстоятелствата НСР-6938/12.08.2015 |
НСР-3734/06.06.2014 |
23.06.2014 |
23.06.2014 |
Неактивен |
2925 |
| Docetaxel |
№ II-10282/16.07.2010г. |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 16 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK, Ltd Queensway Royal Leamington Spa Warwiskshire CV313RW, Обединеното кралство;Hospira S.p.a Via Fosse Ardeatine 2, Liscate, Италия |
200.39 |
40.08 |
240.47 |
4% |
8.02 |
208.41 |
41.68 |
250.09 |
16% |
25 |
233.41 |
46.68 |
280.09 |
цената е заличена с решение НСР-6947/12.08.2015 (в сила от 02.09.2015 ) |
НСР-6501/18.06.2015 |
04.07.2015 |
04.07.2015 |
Заличен |
1299 |
| Docetaxel |
20100475 |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 2 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK Ltd. QUEENSWAY, Великобритания, Hospira S.p.A, Италия |
18.8 |
3.76 |
22.56 |
6% |
1.13 |
19.93 |
3.99 |
23.92 |
18% |
3.38 |
23.31 |
4.66 |
27.97 |
цената е заличена с решение НСР-6654/09.07.2015 (в сила от 02.08.2015 ) |
НСР-3735/06.06.2014 |
23.06.2014 |
23.06.2014 |
Заличен |
2924 |
| Docetaxel |
№ II-10282/16.07.2010г. |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 16 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK, Ltd Queensway Royal Leamington Spa Warwiskshire CV313RW, Обединеното кралство;Hospira S.p.a Via Fosse Ardeatine 2, Liscate, Италия |
583.44 |
116.69 |
700.13 |
4% |
10 |
593.44 |
118.69 |
712.13 |
16% |
25 |
618.44 |
123.69 |
742.13 |
|
НСР-3182/07.04.2014 |
21.04.2014 |
21.04.2014 |
Неактивен |
1299 |
| Docetaxel |
№ II-10282/16.07.2010г. |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 16 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK, Ltd Queensway Royal Leamington Spa Warwiskshire CV313RW, Обединеното кралство;Hospira S.p.a Via Fosse Ardeatine 2, Liscate, Италия |
687 |
137.4 |
824.4 |
4% |
10 |
697 |
139.4 |
836.4 |
16% |
25 |
722 |
144.4 |
866.4 |
|
КЦРР-1177/08.08.2012 |
24.08.2012 |
24.08.2012 |
Неактивен |
1299 |
| Docetaxel |
20100475 |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 2 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK Ltd. QUEENSWAY, Великобритания, Hospira S.p.A, Италия |
86 |
17.2 |
103.2 |
4% |
3.44 |
89.44 |
17.89 |
107.33 |
16% |
13.76 |
103.2 |
20.64 |
123.84 |
|
НСР-1214/23.09.2013 |
11.10.2013 |
11.10.2013 |
Неактивен |
2924 |
| Docetaxel |
№ ІІ - 10282/16.07.2010 |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 2 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK Ltd. QUEENSWAY, Великобритания, Hospira S.p.A, Италия |
154.51 |
30.9 |
185.41 |
4% |
6.18 |
160.69 |
32.14 |
192.83 |
16% |
24.72 |
185.41 |
37.08 |
222.49 |
|
КЦ-2370-a/22.06.2011 |
07.07.2011 |
07.07.2011 |
Неактивен |
2924 |
| Docetaxel |
20100475 |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 8 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK Ltd. QUEENSWAY, Великобритания, Hospira S.p.A, Италия |
343.95 |
68.79 |
412.74 |
4% |
10 |
353.95 |
70.79 |
424.74 |
16% |
25 |
378.95 |
75.79 |
454.74 |
|
НСР-1214/23.09.2013 |
11.10.2013 |
11.10.2013 |
Неактивен |
2925 |
| Docetaxel |
№ ІІ - 10282/16.07.2010 |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 8 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK Ltd. QUEENSWAY, Великобритания, Hospira S.p.A, Италия |
616.09 |
123.22 |
739.31 |
4% |
10 |
626.09 |
125.22 |
751.31 |
16% |
25 |
651.09 |
130.22 |
781.31 |
|
КЦ-2369-a/22.06.2011 |
07.07.2011 |
07.07.2011 |
Неактивен |
2925 |
| Docetaxel |
EU/1/12/770/001 |
Docetaxel Kabi, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Fresenius Kabi Oncology Plc., Обединено Кралство |
Fresenius Kabi Oncology Plc., Lion Court Farnham Road, Bordon, Hampschire GU35 0NF Обединено кралство |
86.06 |
17.21 |
103.27 |
4% |
3.44 |
89.5 |
17.9 |
107.4 |
16% |
13.77 |
103.27 |
20.65 |
123.92 |
|
НСР-7022/25.08.2015.; НСР-10939/17.11.2016; НСР-18078/01.03.2019 |
06.12.2016 |
02.04.2019 |
Заличен |
969 |
| Docetaxel |
EU/1/12/770/001 |
Docetaxel Kabi, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Fresenius Kabi Oncology Plc., Обединено Кралство |
Fresenius Kabi Oncology Plc., Lion Court Farnham Road, Bordon, Hampschire GU35 0NF Обединено кралство |
86.06 |
17.21 |
103.27 |
4% |
3.44 |
89.5 |
17.9 |
107.4 |
16% |
13.77 |
103.27 |
20.65 |
123.92 |
|
НСР-7022/25.08.2015.; НСР-10939/17.11.2016 |
06.12.2016 |
02.01.2017 |
Неактивен |
969 |
| Docetaxel |
EU/1/12/770/001 |
Docetaxel Kabi, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Fresenius Kabi Oncology Plc., Обединено Кралство |
Fresenius Kabi Oncology Plc., Lion Court Farnham Road, Bordon, Hampschire GU35 0NF Обединено кралство |
167.81 |
33.56 |
201.37 |
4% |
6.71 |
174.52 |
34.9 |
209.42 |
16% |
25 |
199.52 |
39.9 |
239.42 |
|
НСР-7022/25.08.2015. |
10.09.2015 |
10.09.2015 |
Неактивен |
969 |
| Docetaxel |
EU/1/12/770/001 |
Docetaxel Kabi, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Fresenius Kabi Oncology Plc., Обединено Кралство |
Fresenius Kabi Oncology Plc., Lion Court Farnham Road, Bordon, Hampschire GU35 0NF Обединено кралство |
268.44 |
53.69 |
322.13 |
4% |
10 |
278.44 |
55.69 |
334.13 |
16% |
25 |
303.44 |
60.69 |
364.13 |
|
НСР-3539/16.05.2014 |
03.06.2014 |
03.06.2014 |
Неактивен |
969 |
| Docetaxel |
EU/1/12/770/001 |
Docetaxel Kabi, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Fresenius Kabi Oncology Plc., Обединено Кралство |
Fresenius Kabi Oncology Plc., Lion Court Farnham Road, Bordon, Hampschire GU35 0NF Обединено кралство |
378.71 |
75.74 |
454.45 |
4% |
10 |
388.71 |
77.74 |
466.45 |
16% |
25 |
413.71 |
82.74 |
496.45 |
|
НСР-929/12.08.2013 |
02.09.2013 |
02.09.2013 |
Неактивен |
969 |
| Docetaxel |
EU/1/12/770/001 |
Docetaxel Kabi, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Fresenius Kabi Oncology Plc., Обединено Кралство |
Fresenius Kabi Oncology Plc., Lion Court Farnham Road, Bordon, Hampschire GU35 0NF Обединено кралство |
406.97 |
81.39 |
488.36 |
4% |
10 |
416.97 |
83.39 |
500.36 |
16% |
25 |
441.97 |
88.39 |
530.36 |
|
КЦРР-1736/04.12.2012 г |
20.12.2012 |
20.12.2012 |
Неактивен |
969 |
| Docetaxel |
20190146 |
Docetaxel Novamed, Concentrate for solution for infusion, 20 mg/ml - 8 ml, -, Pack: 1 |
Новамед Трейдинг ЕООД, България |
Seacross Pharmaceuticals Limited, Обединено кралство |
129.08 |
25.82 |
154.9 |
4% |
5.16 |
134.24 |
26.85 |
161.09 |
16% |
20.65 |
154.89 |
30.98 |
185.87 |
|
НСР-19926/10.10.2019 |
25.10.2019 |
02.11.2019 |
Активен |
16740 |